ライフサイエンスコーパス: intravenous injection

1 lies on cell homing to the bone marrow after intravenous injection.

2 directly into the ossicle marrow space or by intravenous injection.

3 ssess the biodistribution of the cells after intravenous injection.

4 SB0010853 was assessed ex vivo at 24 h after intravenous injection.

5 4.1.1 did not affect survival in the lung on intravenous injection.

6 ght on f-MWNT's brain distribution following intravenous injection.

7 magnetic resonance (MR) imaging of tumors by intravenous injection.

8 lly improve drug delivery to the brain after intravenous injection.

9 were carried into the brain after peripheral intravenous injection.

10 ult mouse central nervous system (CNS) after intravenous injection.

11 body (89)Zr PET and (19)F MRI after a single intravenous injection.

12 on scan, (11)C-nicotine was administered via intravenous injection.

13 C3 levels in FH-deficient mice 2 hours after intravenous injection.

14 ssion for at least 10days following a single intravenous injection.

15 within a U87MG xenograft in nu/nu rats after intravenous injection.

16 s achieved 4 weeks after a single AAV9-R735X intravenous injection.

17 ly reduced AAV2 liver transduction following intravenous injection.

18 peak organ activities occur later than after intravenous injection.

19 LENK itself is inactive on intravenous injection.

20 m Il10(-/-) or Il10(-/-)Tnfr2(-/-) donors by intravenous injection.

21 stribute to the central nervous system after intravenous injection.

22 lcified elastic lamina when administrated by intravenous injection.

23 ake within vessel wall lesions compared with intravenous injection.

24 bite but not when they were administered by intravenous injection.

25 uspension through intranasal instillation or intravenous injection.

26 xposure of healthy organs when compared with intravenous injection.

27 which was mostly cleared within 10 min after intravenous injection.

28 sociated virus (AAV) 1, 2, 6, 8, and 9 after intravenous injection.

29 n of tumor cells within the animal following intravenous injection.

30 "wild-type pHLIP," over time after a single intravenous injection.

31 higher than in the opposite kidney and after intravenous injection.

32 CT1(high) cells formed more metastases after intravenous injection.

33 odel despite minimal tumor accumulation upon intravenous injection.

34 , comparable to a 1.76-fold increase through intravenous injection.

35 d AuNPs accumulated in the mouse brain after intravenous injection.

36 ciency of urinary iron excretion compared to intravenous injection.

37 imination into urine after a single low-dose intravenous injection.

38 hronic toxicity at day 180 after single-dose intravenous injection.

39 on scan, (11)C-nicotine was administered via intravenous injection.

40 layed a maximal tumor accumulation 3 h after intravenous injection (22 %IA/g), with an excellent tumo

41 , NIH:OVCAR-3) were injected repeatedly (1-3 intravenous injections 7-10 d apart, allowing bone marro

42 , NIH:OVCAR-3) were injected repeatedly (1-3 intravenous injections 7-10 d apart, allowing bone marro

43 urvival in the lungs of mice colonized after intravenous injection, a feature diminished by TF or ZEB

44 On intravenous injection, a nanoparticle formulation of MET

45 After a single low-dose intravenous injection and a clearance time of approximat

46 brain, heart, spleen and kidneys 48 h after intravenous injection and can be detected 14 days after

47 of inducing benefits peripherally following intravenous injection and in the brain at FUS-targeted a

48 magnetic drug targeting (MDT) through either intravenous injection and pulmonary delivery for lung ca

49 the gastrointestinal tract of mice following intravenous injection and readily transmits to cohoused

50 r than levels seen following subcutaneous or intravenous injection and would result in minimal system

51 tramuscular injection), lung and spleen (via intravenous injection), and brain (via lateral ventricle

52 plasma half-life of 113 h in minipigs after intravenous injection, and acceptable chemical stability

53 in human xenograft tumors in mice following intravenous injection, and the retention of particles is

54 atic nerve injection and intraperitoneal and intravenous injection as well as intrathecal injection.

55 mes was evaluated in adult rats after single intravenous injection at dose of 15.2mumoles of phosphol

56 2 rats implanted with C6 glioma received two intravenous injections at a 24-hour interval.

57 ity were intramuscular tuberculosis therapy, intravenous injections at hospital A, intravenous inject

58 Intravenous injections at hospital B and antimalarials w

59 k factors for HTLV-1 seropositivity included intravenous injections at hospitals C or D and transfusi

60 erapy, intravenous injections at hospital A, intravenous injections before 1960, and injections at a

61 paramagnetic iron oxide nanoparticles before intravenous injection, before and following BBB disrupti

62 sappeared from blood almost immediately post-intravenous injection, but numerous cell-derived micropa

63 After saline intravenous injection, cardiac contractility was signifi

64 Intravenous injection caused an increase of IL-6 in the

65 g for intra-tumoral injection or 6 mg/kg for intravenous injection delivered up to 4 times) was well-

66 Intravenous injection facilitated tissue-specific, multi

67 Patients were given TPCS2a on day 0 by slow intravenous injection, followed by a fixed dose of 15 00

68 enous glyburide was given as a 0.13 mg bolus intravenous injection for the first 2 min, followed by a

69 With intravenous injection, for which both reduction and reco

70 Following intravenous injections, GeRPs containing siRNA against p

71 Systemic transfer of DCs by intravenous injection has been widely investigated to in

72 hermore, in vivo miR-126 upregulation (mimic intravenous injection) improved cardiac vascular density

73 icle uptake and retention kinetics following intravenous injection in a controlled cortical impact mo

74 d blood clearance and a low background after intravenous injection in cynomolgus monkeys.

75 d-BSA (bovine serum albumin) following their intravenous injection in live rats.

76 ere verified to traffic into the brain after intravenous injection in mice, and both cellular and in

77 onger plasma circulation than free drug upon intravenous injection in mice.

78 Following intravenous injection in the tail veins of homozygous M8

79 0 nm in diameter (MSNPs500) upon single-dose intravenous injection into male and female immune-compet

80 rbon nanotubes sensors in solution, enabling intravenous injection into mice and the selective detect

81 nd mRNA encoding Cas9, we show that a single intravenous injection into mice induces >80% editing of

82 zed and attached to virus-size particles for intravenous injection into mice that express a CD172a va

83 arance of thrombolytics from blood following intravenous injection is a major clinical challenge in c

84 the native oligourea in the kidney following intravenous injection is consistent with high stability

85 n a human ovarian cancer xenograft following intravenous injection is demonstrated in a live mouse.

86 Intravenous injection is the least invasive drug deliver

87 tration was compared with change produced by intravenous injection (IV), subcutaneous (SC) injection

88 Following intravenous injection, local activation of the liposomes

89 pe 5 (Ad5) naturally infects the liver after intravenous injection, making it a candidate for hepatoc

90 but still causes brain infection in a murine intravenous injection model, suggesting that the block o

91 Using heterotopic and intravenous injection models of lung metastasis in mice,

92 eural) injection (n = 4), and systemic MSCs (intravenous) injection (n = 4).

93 boons underwent PET scans of the brain after intravenous injection of (11)C-erlotinib under baseline

94 ual-modality imaging was performed 3 d after intravenous injection of (111)In-DTPA-labetuzumab-IRDye8

95 Single-dose intravenous injection of (131)I-CLR1404 significantly de

96 ic small-animal PET imaging for 60 min after intravenous injection of (18)F-AFETP.

97 roximately 7, 45, 90, 130, and 170 min after intravenous injection of (18)F-CP-18 in 7 healthy human

98 glioma-bearing Fischer 344 rats by means of intravenous injection of (18)F-FBPA-Fr both with and wit

99 rmore, the K1/k2 pharmacokinetic ratio after intravenous injection of (18)F-FBPA-Fr with BBB-D was si

100 rain ratio were significantly elevated after intravenous injection of (18)F-FBPA-Fr with BBB-D.

101 rs and the tumor-to-normal brain ratio after intravenous injection of (18)F-FBPA-Fr with sonication w

102 Acquisition started 1 min after intravenous injection of (18)F-FCH (4.07 MBq/kg of body

103 y) each underwent a 90-min PET scan after an intravenous injection of (18)F-GE-179.

104 re obtained for 1 h beginning at the time of intravenous injection of (18)F-Gln.

105 iodistribution and radiation dosimetry after intravenous injection of (18)F-MCL-524.

106 Blood monocytes were labeled by intravenous injection of (19)F-perfluorocarbon emulsion

107 were treated 13 d after engraftment with an intravenous injection of (212)Pb-daratumumab or control

108 ere treated 13 days post-engraftment with an intravenous injection of (212)Pb-Daratumumab or control

109 tion were evaluated at different times after intravenous injection of (64)Cu-alphaCD11b.

110 saline (n = 5) by using PET performed after intravenous injection of (64)Cu-DOTA-ECL1i.

111 ody PET scans at different time points after intravenous injection of (64)CuCl2.

112 Conclusion: Intravenous injection of (68)Ga-DOTA-Siglec-9 was safe a

113 Patients received a single 150-MBq intravenous injection of (68)Ga-DOTATOC (15 mug of pepti

114 /CT images were acquired 60 +/- 10 min after intravenous injection of (68)Ga-PSMA (mean dose, 176 MBq

115 V/Q SPECT scans were performed after intravenous injection of (99m)Tc-macroaggregated albumin

116 ice (weight +/- SD, 28.2 +/- 2.1 g) received intravenous injection of 0.75 +/- 0.33 MBq of (-)-(18)F-

117 s intravenously administered, followed by an intravenous injection of 1.2 mg/kg lexaptepid or placebo

118 An intravenous injection of 1.5 ml/kg of body mass of non-i

119 Patients were randomized to receive an intravenous injection of 10 mug of IFN-beta-1a (144 pati

120 Intravenous injection of 10(6) 5T33 mouse myeloma cells

121 After intravenous injection of 100 MBq of the tracer, 4 succes

122 onies were induced in athymic BALB/c mice by intravenous injection of 100 muL of a GW-39 cell suspens

123 PET/CT was performed after intravenous injection of 132-222 MBq of (68)Ga-DOTANOC.

124 d samples were drawn from 1 to 240 min after intravenous injection of 162 +/- 4 MBq of (68)Ga-DOTA-Si

125 We show that intravenous injection of 25,000 C. albicans cells causes

126 e effects were observed within 90 days after intravenous injection of 250 mg kg(-1) GS-AuNPs.

127 CP18 uptake after intravenous injection of 250 muCi of 18F-CP18, 24 hours

128 r up to 240 min using a PET/CT scanner after intravenous injection of 299 +/- 22.5 MBq of (18)F-FSPG.

129 ndex 1.3) was performed for 10 minutes after intravenous injection of 2x10(8) lipid microbubbles.

130 After intravenous injection of 2x200 microL of a perfluorocarb

131 or HER2-negative (n = 11) histopathology, an intravenous injection of 385 +/- 125 MBq of (99m)Tc-ADAP

132 ing a dedicated small-animal US system after intravenous injection of 5 x 10(7) clinical-grade VEGFR2

133 milies CYP2D and CYP3A were inhibited before intravenous injection of [(11)C]PD153035 into healthy an

134 We found that intravenous injection of [Thr(28),Nle(31)]CCK increased

135 A-4-targeted PET/CT was performed 24 h after intravenous injection of a (64)Cu-labeled high-affinity

136 the retinal vasculature without the need for intravenous injection of a fluorophore.

137 on of endogenously generated MDA epitopes by intravenous injection of a specific MDA antibody results

138 approximately 2-m-old affected dogs received intravenous injection of a tyrosine-engineered AAV-9 rep

139 An intravenous injection of AAV8 containing firefly lucifer

140 Intravenous injection of AITC evoked bradycardia but no

141 Intravenous injection of alpha-galactosylceramide activa

142 med 10 d after 5T33 cell engraftment with an intravenous injection of an antimouse CD138 antibody rad

143 he technology involves HSPC mobilization and intravenous injection of an integrating HDAd5/35++ vecto

144 Intravenous injection of anti-MPO IgG induced glomerular

145 Anaphylaxis was induced by intravenous injection of antigen or anti-huIgE mAb.

146 e point, treatment of animals was started by intravenous injection of antithrombin (250 IU/kg body we

147 -negative (n = 2) primary tumors received an intravenous injection of approximately 100 mug ( approxi

148 or growth was significantly inhibited by the intravenous injection of APRPG-miR-499 at such a low dos

149 thelialium-specific activation of miR-195 by intravenous injection of aptamer-agomiR-195 stimulates C

150 ozoites (PfSPZ) inoculated by mosquitoes; by intravenous injection of aseptic, purified, radiation-at

151 Moreover, the intravenous injection of BAMEA-O16B/Cas9 mRNA/sgRNA nano

152 underwent dynamic whole-body PET/CT after an intravenous injection of BAY 86-7548 (138 +/- 5 MBq).

153 The patients then received a single intravenous injection of BIVV001 at the same correspondi

154 lving men with severe hemophilia A, a single intravenous injection of BIVV001 resulted in high sustai

155 Consistently, the intravenous injection of breast cancer cells with ectopi

156 Intravenous injection of C/EBPalpha-saRNA in a cirrhotic

157 Here, we showed that intravenous injection of calpain3-expressing vector in m

158 e) than in regular NSG mice 3 weeks after an intravenous injection of CD34 human cord blood cells.

159 From scans before and after intravenous injection of contrast material, we measured

160 nt was observed in the diffuse pattern after intravenous injection of contrast material.

161 this study we investigated the effect of an intravenous injection of corticotropin-releasing factor

162 Simultaneous intravenous injection of CXCL9(74-103) with CXCL8 inject

163 a murine model of gout, is highly reduced by intravenous injection of CXCL9(74-103).

164 Single intravenous injection of DC nanozymes (5kU of SOD1/kg) i

165 levels of hepatic transgene expression after intravenous injection of dendrimer-coated Ad5-CMV/NIS (d

166 In this study, we show that an acute intravenous injection of docosahexaenoic acid (DHA) 30 m

167 We previously showed that an intravenous injection of doxorubicin-free Doxil-like PEG

168 erfusion and then 1 d after MCAO received an intravenous injection of either PBS (control, n = 10), P

169 Bacteremia was induced by intravenous injection of Escherichia coli Bacteremia cau

170 s process, bacteremia was induced in mice by intravenous injection of Escherichia coli.

171 remaster artery laser injury model, a single intravenous injection of exenatide inhibited thrombus fo

172 In vivo experiments revealed that intravenous injection of exosomes harvested after T/HS,

173 stem cells (MSCs) were labeled in vivo with intravenous injection of ferumoxytol (Feraheme; AMAG Pha

174 immunocompetent Sprague-Dawley rats received intravenous injection of ferumoxytol, and 18 Jax C57BL/6

175 in WT mice was significantly increased after intravenous injection of FHL2(-/-) versus WT EOCs.

176 ing, a 2D fundus photograph that requires an intravenous injection of fluorescent dye.

177 By intravenous injection of fluorescent high-molecular weig

178 Furthermore, intravenous injection of FS50 into rats and monkeys elic

179 ted the endocochlear potential in vivo by an intravenous injection of furosemide and measured the vib

180 and EP while using intraperitoneal (IP) and intravenous injection of furosemide to reversibly reduce

181 seudo-metastatic lung mouse model, following intravenous injection of gammadelta T cell, L-ALD or the

182 the preclinical pig kidney transplant model, intravenous injection of GC7 before kidney removal signi

183 Acute intravenous injection of glucose induced hyperglycemia a

184 T-cell tolerance was induced by means of intravenous injection of hapten conjugated to self-antig

185 ossible way to improve MRCP is using it with intravenous injection of hepatobiliary-specific contrast

186 Intravenous injection of histamine was sufficient to eli

187 After a single intravenous injection of human CD34+ cells, NSG-SGM3 mic

188 MR spectroscopy were performed at 7 T during intravenous injection of hyperpolarized [1-(13)C]-pyruva

189 Systemic intravenous injection of ICAM-1 antibody (anti-ICAM-1) a

190 Intravenous injection of IL-33 or pulmonary fungal aller

191 Remarkably, intravenous injection of IL4I1 into mice with experiment

192 roach that involves HSPC mobilization and an intravenous injection of integrating HDAd5/35++ vectors.

193 In mice, intravenous injection of Lac-GLN containing Cy3-anti-miR

194 The procedures included (1) intravenous injection of lentiviral TRPC3 channel or non

195 Intravenous injection of LV12 cells produced more liver

196 The next day, mice received a 100 mg/kg intravenous injection of metformin.

197 dministered to the mice in vivo, followed by intravenous injection of microbubbles and FUS sonication

198 Intravenous injection of MN-anti-miR10b into mice bearin

199 targeting MPO activity were performed after intravenous injection of MPO sensors (bis-5-hydroxytrypt

200 Intravenous injection of Ms 9a-1 (0.3 mg/kg) produced a

201 Intravenous injection of NAD(+) increased the level of e

202 Intravenous injection of nanoparticles resulted in non-s

203 In mice with laser-induced CNV, intravenous injection of NP-[CPP] coupled to irradiation

204 rains were scanned with PET for 90 min after intravenous injection of one of the candidate radioligan

205 Intravenous injection of PARPi-FL allowed for high contr

206 Intravenous injection of PARPi-FL has significant potent

207 A single intravenous injection of PEG-Cp40 resulted in a prolonge

208 ontrolled cortical impact injury received an intravenous injection of PEGylated NP cocktail (20, 40,

209 gen-deficient mice, but could be restored by intravenous injection of plasminogen.

210 st was induced in female large white pigs by intravenous injection of potassium chloride.

211 Intravenous injection of ppp-TGF-beta reduced systemic a

212 natal mice (postnatal day 0-1), we show that intravenous injection of rAAV2/9 carrying an eGFP-report

213 ctor VIII activity, <1%) to receive a single intravenous injection of recombinant factor VIII at a do

214 In this study, we show that intravenous injection of recombinant murine CIRP (rmCIRP

215 Upon intravenous injection of rGluc followed by its substrate

216 Intravenous injection of S1P in anesthetized rats reduce

217 We also show that intravenous injection of singly encapsulated marrow stro

218 Intravenous injection of small amounts of recombinant DB

219 Intravenous injection of tat-cyclotraxin-B dose-dependen

220 usly hypertensive (SH) rat to inhalation and intravenous injection of the noxious stimuli allyl isoth

221 tions such as controlled drug delivery where intravenous injection of the particles is intended.

222 Importantly, intravenous injection of the probe led to targeted uptak

223 Finally, intravenous injection of the rAAV-Fkrp vector into a dys

224 After intravenous injection of the radioligands in Danish Land

225 biae from the LysM(Cre)/Tgfbr2 KO group, and intravenous injection of the recombinant bFGF to LysM(Cr

226 gnaling in adult Sema3aloxP/loxP mice by the intravenous injection of the recombinant TAT-Cre protein

227 ashout period >/= 4 wk, subjects received an intravenous injection of the same compound (214 nmol).

228 y reactivate from latency following a single intravenous injection of the synthetic corticosteroid de

229 A single intravenous injection of the synthetic corticosteroid de

230 After intravenous injection of the tracer (198.3 +/- 3.3 MBq),

231 At 24 h after intravenous injection of the tracer (64)CuCl2, the (64)C

232 At 24 h after intravenous injection of the tracer, uptake was signific

233 In vivo, the intravenous injection of transferrin-bearing dendriplex

234 However, following intravenous injection of tumor cells, mice lacking PITPa

235 Six patients received 2 intravenous injections of (223)Ra-dichloride, 6 wk apart

236 TOC (15 mug of peptide) and 2 single 150-MBq intravenous injections of (68)Ga-OPS202 (15 mug of pepti

237 Patients received 2 single 150-MBq intravenous injections of (68)Ga-OPS202 3-4 wk apart (15

238 Tumor-bearing mice received 2 intravenous injections of 100 muL of saline, 30 MBq of (

239 tee-approved study, healthy rats received 20 intravenous injections of 2.5 mmol gadolinium per kilogr

240 onitored in anesthetized rats in response to intravenous injections of 20% glucose (w/v), 5 U/kg insu

241 Intravenous injections of a specific miR-155 inhibitor w

242 Anesthetized lambs were embolized with intravenous injections of autologous blood clots or repe

243 onal cholesterol absorption, mice were given intravenous injections of cholesterol D5 and oral choles

244 A discrete cue associated with intravenous injections of cocaine acquires greater contr

245 ring nude mice that received intratumoral or intravenous injections of Dox@PEG-HAuNS, fluorescence op

246 In chow-fed mice, acute or chronic intravenous injections of EDPs induced hyperglycemic eff

247 Intravenous injections of elastin antibody-conjugated BB

248 Mice were given acetaminophen gavage or intravenous injections of fluorescently labeled Escheric

249 Furthermore, intravenous injections of GDNF-macrophages at an early s

250 the last 3 weeks, a subset of rats received intravenous injections of lipopolysaccharide (LPS, 3 mg/

251 Bolus intravenous injections of microbubbles are standard prac

252 Colitis was induced in Rag2(-/-) mice by intravenous injections of naive CD8(+) T cells isolated

253 Long-term prophylaxis with twice-weekly intravenous injections of plasma-derived C1-inhibitor (p

254 andomly assigned (2:1) to receive either six intravenous injections of radium-223 (50 kBq/kg) or matc

255 ive response technology to receive up to six intravenous injections of radium-223 (55 kBq/kg) or matc

256 Patients received intravenous injections of radium-223, 50 kBq/kg (current

257 Repeated intravenous injections of recombinant APRIL before and e

258 Intravenous injections of RGD-targeted ECO/sibeta3 nanop

259 Intravenous injections of RNA-paclitaxel nanoparticles w

260 Three intravenous injections of the Fcmu-drug conjugate over a

261 Intravenous injections of the PHP.eB-iMecp2 virus in sym

262 eropathy (model 3) models of celiac disease, intravenous injections of TIMP-GLIA significantly decrea

263 Cln3(Deltaex7/8) mice received one systemic (intravenous) injection of scAAV9/MeCP2-hCLN3 or scAAV9/b

264 Systemic injection, such as intravenous injection only delivers a small proportion o

265 arTATE or (177)Lu-LuTATE, either as a single intravenous injection or as two 15-MBq fractions 2 wk ap

266 The radiotracer was administered as a bolus intravenous injection or bolus plus constant infusion (t

267 available cyanide antidotes must be given by intravenous injection over 5-10 min, making them ill-sui

268 howed that after subchronic therapy of three intravenous injections over 5weeks at 2mg/kg, antimiR-14

269 precisely with lower background noise after intravenous injection, owing to the multifunctional resp

270 ficantly after intraperitoneal compared with intravenous injection (P<0.01).

271 Compared with intravenous injection, pdC1-INH SC injection with CSL830

272 of nanoparticle contrast agent required for intravenous injection relative to absorption-based x-ray

273 perimental infection of GPgV in goslings via intravenous injection revealed robust replication and hi

274 The longer, clinically preferred intravenous injection scheme is sufficiently accurate fo

275 d hyperglycemia, mice that received HK BF by intravenous injection showed rapid disease progression.

276 the intervention group, patients received 5 intravenous injections spaced 12 h apart during the firs

277 are, and are significantly more likely after intravenous injection than after intramuscular injection

278 ferroptosis and formed more metastases after intravenous injection than did melanoma cells from subcu

279 First, after a singledose intravenous injection, the nanochelator shows favorable

280 Upon intravenous injection, the Ter119-NPs achieved remarkabl

281 Through a single intravenous injection, these materials can image microme

282 sorb onto the surface of nanoparticles after intravenous injection to form a protein corona.

283 ion-competent vaccinia virus administered by intravenous injection, to target the tumor vasculature,

284 After intravenous injection, up to 90% of lipid nanoparticles

285 e 5TGM1-GFP syngeneic tumors generated after intravenous injection via the tail.

286 ighest tumor-to-muscle ratio at 60 min after intravenous injection was found in the untreated animals

287 ex vivo USF imaging of the mouse spleen via intravenous injections was also successfully achieved.

288 elivery vehicle for Cre mRNA in vivo through intravenous injection, we achieved 8.2 % gene recombinat

289 were corroborated in a mouse model following intravenous injection, where active YAP increased the nu

290 rves showed a biexponential decrease for the intravenous injection, whereas a slow increase followed

291 retention of GC-PEG-PpIX were realized after intravenous injection, which ensured its effective imagi

292 ctional for systemically delivered siRNA via intravenous injection, which would subject siRNA to seve

293 ts were imaged at multiple time points after intravenous injection with 362 +/- 8 MBq of CTT1057 to e

294 ndividuals were inoculated by intradermal or intravenous injection with cryopreserved, isogenic NF54

295 All subjects received an intravenous injection with lipopolysaccharide.

296 Intravenous injection with preformed fibrils from islet

297 by BCR-ABL1-expressing stem cells following intravenous injection, with leukemogenesis restored by d

298 B-D was significantly higher than that after intravenous injection without BBB-D.

299 used for amyloid plaque detection in vivo by intravenous injection without the need to co-inject an a

300 quid-lipid nanoparticle system (CPA-LLP) for intravenous injection would have desirable pharmacokinet